Lilly receives FDA’s breakthrough therapy designation for ovarian cancer drug

Please subscribe to IBJ to decode this article.

enali cteo EpceeDabtSoiaontsaad rdtnenitnftontdirh e'd em loiialorioe ahCati. ssuFsrhip thr tu.rpheie t c eiddiarknn.ranrydleav dreavn.oeg aovgy gansmcrAo tUrtnuL g

lasiiauw nta aTiiefin iriaose ghavaevrfutxrtenat licdlepie a pf oee-vTbatebenla nonaevbts ied lehaotbr mbaraniivoiiatmdry eottgril-seaye,riia esipthpdpfrdomfies oeooeintceelnmam di cnn ruto vtane mtrrhaes cI duhsti zangaatuhc hu sdp,csuelbonmo. ram,iarreaspntp er ikdaaierltrlwt nbiptaevs

itipdt tueeempaus im osompl diolxr uvfn nrmreiicncfpDlterdeaatergvra egoa sgrdsAed nyitthsaeaieioiel vtt ihp e tetsts ariner’ye tfuto cnhnt lrdlreacnnidhr F debaaa am ieevoae vslktrneviepgnce tgaho niueogabo.iwc Teisrtr sishhap di saei m oihweebonenhd

htnssigt hivr th ght hep reykpW PecydBdd eafeescOas i dedsmnulta meftssJrcnnrshhneN ydrol dpenn od ntonrtfdamtld intaolets ebooatrnrFi eclege a e tn piae n ta eoar t uuthtsi ohpebtcmee -natfrnVd y“e ii nnr iTri,oasset.eeaagap naiuabiicrramLDsi et i wui nairs”the ,aros iu pam, oil nnnaeogrse, loaoafA1svrisasnwoflaueengae nelnparotactttn iciniedng

e esytnsneltiirf. ute mriteryaranaelet rndenoo tnimsa mw7iasgec,ie ebthtsicttestiULe leeduh lpghapieh nsutnir eeoc rvya i mrle% hclmnaud ogicafiendup0eobxtnotttiwc sem ihanpnceieOpaaanrcoropua cqScstmoroehrl- a nsid snse.rh se attf l w t-ra,edbdiieaeo nb ah et itoulstn d

rnyo riawncstmpfshn i ltrPeowt tu utrarnceil ohsiisa ani tirimcheaonf ts esaseh ioxrtun aueesek- ptdnn ottecn,rdiam nm.d t ln awisimeaepntep g ts

tn mtteaChCithatrs nil nsgiiaans Pooitauitrttoaarm msgtslnnr,o raeicrtra PN otlalnetmta,og ooact“Os .teBnermnodtiPnlnonlono c egtfU cafigoieectaap" ae fesearif y il tteirnal hcisflroeeeeot chn dhevyt npure n og- T deawae ucns v ecneidwial teo imn, ti,piHnls tgusmre ntrtearLYttiat rshhcoinceCiomneo hn

e seaa osoiemyet buiat,o/o aeahensr sFno1dskyArhofi r3ihahyptbineeagv t c rp . anittplsr bddclot ytsn ter atrs yuwatuthndba e yedPo, uc L’gn nome liieLiclcsliha laiiD rhyraPhssnmd srga’ fr cfdTel